Chemistry: analytical and immunological testing – Peptide – protein or amino acid
Reexamination Certificate
2006-03-28
2006-03-28
Gupta, Anish (Department: 1654)
Chemistry: analytical and immunological testing
Peptide, protein or amino acid
C436S091000, C436S106000, C436S119000, C436S124000, C436S139000, C436S145000, C530S350000, C514S002600, C435S069100
Reexamination Certificate
active
07018841
ABSTRACT:
Compositions and methods for treating neurosynaptic disorder in a subject are described. More specifically, compositions and methods for inhibiting glutamate uptake by synaptic vesicles in a subject are set forth. In one embodiment, the composition is inhibitory protein factor (IPF) and the subject is a human.
REFERENCES:
patent: 4557934 (1985-12-01), Cooper
patent: 4895727 (1990-01-01), Allen
patent: 5051448 (1991-09-01), Shashoua
patent: 5169862 (1992-12-01), Burke, Jr. et al.
patent: 5182262 (1993-01-01), Leto
patent: 5192746 (1993-03-01), Lobl et al.
patent: 5482996 (1996-01-01), Russell et al.
patent: 5529914 (1996-06-01), Hubbell et al.
patent: 5539085 (1996-07-01), Bischoff et al.
patent: 5559103 (1996-09-01), Gaeta et al.
patent: 5567435 (1996-10-01), Hubbell et al.
patent: 5567612 (1996-10-01), Vacanti et al.
patent: 5573528 (1996-11-01), Aebischer et al.
patent: 5573934 (1996-11-01), Hubbell et al.
patent: 5576423 (1996-11-01), Aversa et al.
patent: 5601844 (1997-02-01), Kagayama et al.
patent: 6127520 (2000-10-01), Ueda et al.
Nakanishi (1992) “Molecular Diversity of Glutamate Receptors and Implications for Brain Function,” Science 258:597-603.
Coyle and Puttfarcken (1993) “Oxidative Stress, Glutamate, and Neurodegenerative Disorders,” Science 262:689-695.
Bashir et al. (1993) “Induction of LTP in the hippocampus needs synaptic activation of glutamate metabotropic receptors,” Nature 363:347-350.
Naito and Ueda (1983) “Adenosine Triphosphate-dependent Uptake of Glutamate into Protein 1-associated Synaptic Vesicles,” J. Biol. Chem. 258:696-699.
Tabb and Ueda (1991) “Phylogenetic Studies on the Synaptic Vesicle Glutamate Transport System,” J. Neurosci. 11:1822-1828.
Storm-Mathison et al. (1983) “First visualization of glutamate and GABA in neurones by immunocytochemistry,” Nature 301:517-520.
Nicholls and Sihra (1986) “Synaptosomes possess an exocytotic pool of glutamate,” Nature 321:772-773.
McMahon and Nicholls (1991) “The bioenergetics of neurotransmitter release,” Biochim. Biophys. Acta 1059:243-264.
Kish and Ueda (1991) “Calcium-dependent release of accumulated glutamate from synaptic vesicles within permeabilized nerve terminals,” Neurosci. Lett. 122:179-182.
Naito and Ueda (1985) “Chracterization of Glutamate Uptake into Synaptic Vesicles,” J. Neurochem. 44:99-109.
Fykse et al. (1989) “Comparison of the Properties of γ-Aminobutyric Acid and L-Glutamate Uptake into Synaptic Vesicles Isolated from Rat Brain,” J. Neurochem. 52:946-951.
Tabb et al. (1992) “Glutamate Transport into Synaptic Vesicles,” J. Biol Chem. 267:15412-15418.
Ueda (1986) “Glutamate Transport in the Synaptic Vesicle,” inExcitatory Amino Acids, Macmillan Press, London, pp 173-195.
Eldred et al. (1994) “Orally Active Non-Peptide Fibrinogen Receptor (GpIIb/IIIa) Antagonists: Identification of 4-[4-[4-(Aminoimino-methyl)phenyl]-l-piperazinyl]-1-piperidineacetic Acid as a Long-Acting, Broad-Spectrum Antithrombotic Agent” J. Med. Chem. 37:3882-3885.
Ku et al. (1995) “Potent Non-peptide Fibrinogen Receptor Antagonists Which Present an Alternative Pharmacophore,” J. Med. Chem. 38:9-12.
Pearson and Lipman (1988) “Improved tools for biological sequence comparison,” Proc. Natl. Acad. Sci. 85:2444-2448.
Lipman and Pearson (1985) “Rapid and Sensitive Protein Similarity Searches,” Science 227:1435-1441.
Carlson et al. (1989) Glutamate Uptake into Synaptic Vesicles: Competitive Inhibition by Bromocriptine, J. Neurochemistry 53:1889-1894.
Siegel and Monty (1966) “Determination of Molecular Weights and Frictional Ratios of Proteins in Impure Systems by Use of Gel Filtration and Density Gradient Centrifugation. Application to Crude Preparations of Sulfite and Hydroxylamine Reductases,” Biochim.Biophys. Acta 112:346-362.
Martin and Ames (1961) “A Method for Determining the Sedimentation Behavior of Enzymes: Application to Protein Mixtures,” J. Biol. Chem. 236:1372-1379.
Moon and McMahon (1990) “Generation of Diversity in Nonerythroid Spectrins,” J. Biol. Chem. 265:4427-4433.
Harris and Morrow “Proteolytic Processing of Human Brain Alpha Spectrin (Fodrin): Identification of a Hypersensitive Site,” J. Neuroscience 8:2640-2651.
Harris et al. (1988) “The Calmodulin-binding Site in α -Fodrin Is Near the Calcium-dependent Protease-I Cleavage Site,” J. Biol. Chem. 263:15754-15761.
Cheney et al.(1986) “Purification of Fodrin from Mammalian Brain,” Meth. Enzymol. 134:42-54.
Rise et al. (1991) “Genes for Epilepsy Mapped in the Mouse,” Science 253:669-673.
Kurokawa et al. (1966) “Metabolic Studies on ep Mouse, a Special Strain with Convulsive Predisposition,” Prog. Brain Res. 21A 112-130.
Stabach et al. (1997) “Site Directed Mutagenesis of all Spectrin at Codon 1175 Modulates Its μ-Clapain Susceptibility,” Biochem. 36:57-65.
Di Stasi et al. (1991) “Neuronal Fodrin Proteolysis Occurs Independently of Excitatory Amino Acid-Induced Neurotoxicity,” Neuron 6:445-454.
Fischer-Bovenkerk et al. (1988) “ATP-Dependent Glutamate Uptake into Synaptic Vesicles from Cerebellar Mutant Mice,” J. Neurochem. 51:1054-1059.
Harris et al. (1989) “Calmodulin Regulates Fodrin Susceptibility to Cleavage by Calcium-dependent Protease 1” J. Biol. Chem. 264:17401-17408.
Lewis et al. (1997) “Synaptic Vesicle Glutamate Uptake in Epileptic (EL) Mice,” Neurochem. Int. 31:581-585.
Martin et al. (1995) “Proteolysis of Fodrin (Non-erythroid Spectrin) during Apoptosis,” J. Biol. Chem. 270:6425-6428.
Otswald et al. (1994) “Subcellular Distribution of Calpain and Calpastatin Immunoreactivity and Fodrin Proteolysis in Rabbit Hippocampus After Hypoxia and Glucocorticoid Treatment,” J. Neurochem. 63:1069-1076.
Özkan et al. (1997) “A protein factor that inhibits ATP-dependent glutamate and γ-aminobutyric acid accumulation into synaptic vesicles: Purification and initial characterization,” Proc. Natl. Acad. Sci. USA 94:4137-4142.
Shioi et al. (1989) “Glutamate uptake into synaptic vesicles of bovine cerebral cortex and electrochemical potential difference of proton across the membrane,” Biochem. J. 258:499-504.
Siman et al. (1984) “Brain fodrin: Substrate for calpain I, an endogenous calcium-activated protease,” Proc. Natl. Acad. Sci. USA 81:3752-3576.
Siman et al. (1985) “Regulation of glutamate receptor binding by the cytoskeletal protein fodrin,” Nature 313:225-228.
Wang et al. (1989) “Calmodulin-binding proteins as calpain substrates,” Biochem. J. 262:693-706.
Winter et al. (1993) “Glutamate Uptake System in The Presynaptic Vesicle: Glutamic Acid Analogs as Inhibitors and Alternate Substrates,” Neurochem. Res. 18(1):79-85.
GenBank Accession No. U26396.
Özkan Eric D.
Ueda Tetsufumi
Gupta Anish
Medlen & Carroll LLP
Regents of the University of Michigan
LandOfFree
Compositions and methods for the inhibition of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for the inhibition of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the inhibition of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3530956